TVTX

NASDAQ · Biotechnology

Travere Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$54.98

-0.91 (-1.63%)

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 19 90%

Hold 2 10%

Sell 0 0%

Price Target

Analyst Price Target -32.4% upside

Low Target $26.93

Average Target $37.15

High Target $48.45

Current Price $54.98

Current
$54.98

Target
$37.15

$26.93 $37.15 avg $48.45

Scenario Analysis

Bear Case

$26.93

-51.0%

Low target

Base Case

$37.15

-32.4%

Avg target

Bull Case

$48.45

+-11.9%

High target

Risk/Reward

0.2x

Unfavorable

Price in Context

52-Week High

$60.10

-8.5% from high

52-Week Low

$15.03

+265.8% from low

50-Day SMA

$32.84

+67.4% vs SMA

200-Day SMA

$24.79

+121.8% vs SMA

RSI (14)

40.3

Neutral

Target vs 52W High

$37.15

-38.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	79%	$257.58	+5.4%
AMGN Amgen Inc	Hold	43	49%	$190.87	-52.7%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+179.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-9.5%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-90.0%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-42.1%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-46.0%
BIIB Biogen Inc	Buy	44	64%	$91.45	-55.7%